Article info

Download PDFPDF
Promises and Pitfalls in Erythopoietin-Mediated Tissue Protection


  1. Received May 4, 2010.
  2. Accepted for publication June 15, 2010.
  3. Reprints: Michael Brines, MD, PhD, Warren Pharmaceuticals, 712 Kitchawan Rd, Ossining, NY 10562. E-mail: mbrines{at}
  4. Supported in part by a grant from the National Center for Research Resources (R13 RR023236).
  5. C.C.H. is on the Scientific Advisory Board and owns stock in Warren Pharmaceuticals, which is pursuing the clinical development tissue protective cytokines and peptides.
  6. M.B. is a director and shareholder of Warren Pharmaceuticals.
View Full Text


Hand CC, Brines M
Promises and Pitfalls in Erythopoietin-Mediated Tissue Protection

Publication history

  • First published December 15, 2015.
Online issue publication 
December 15, 2015

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.